BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 8260360)

  • 21. Radiation effects on S-phase duration, labelling index, potential doubling time and DNA distribution in head and neck cancer xenografts.
    Zätterström UK; Engellau J; Johansson MC; Wennerberg J; Kjellén E
    Acta Oncol; 1995; 34(2):205-11. PubMed ID: 7718258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumour cell kinetics as a prognostic factor in squamous cell carcinoma of the cervix treated with radiotherapy.
    Gasińska A; Urbański K; Jakubowicz J; Klimek M; Biesaga B; Wilson GD
    Radiother Oncol; 1999 Jan; 50(1):77-84. PubMed ID: 10225560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of human tumour proliferation using bromodeoxyuridine--current status.
    Wilson GD
    Acta Oncol; 1991; 30(8):903-10. PubMed ID: 1777243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow cytometric measurement of cell cycle kinetics in rat Walker-256 carcinoma following in vivo and in vitro pulse labelling with bromodeoxyuridine.
    Fogt F; Wan J; O'Hara C; Bistrian BR; Blackburn GL; Istfan NW
    Cytometry; 1991; 12(1):33-41. PubMed ID: 1825629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell kinetic studies in mouse tongue mucosa by autoradiographic, immunohistochemical and flow cytometric techniques.
    Dörr W; Arui J; Beisker W; Schultz-Hector S
    Cell Prolif; 1994 Jun; 27(6):321-32. PubMed ID: 10465020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of mathematical formulas used for estimation of DNA synthesis time of bromodeoxyuridine-labelled cell populations with different proliferative characteristics.
    Johansson MC; Baldetorp B; Bendahl PO; Fadeel IA; Oredsson SM
    Cell Prolif; 1996 Oct; 29(10):525-38. PubMed ID: 9051116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry.
    Riccardi A; Danova M; Wilson G; Ucci G; Dörmer P; Mazzini G; Brugnatelli S; Girino M; McNally NJ; Ascari E
    Cancer Res; 1988 Nov; 48(21):6238-45. PubMed ID: 3167869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective evaluation of cell kinetics in head and neck squamous carcinoma: the relationship to tumour factors and survival.
    Cooke LD; Cooke TG; Forster G; Jones AS; Stell PM
    Br J Cancer; 1994 Apr; 69(4):717-20. PubMed ID: 8142259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of cell kinetics in cervical tumours using bromodeoxyuridine.
    Bolger BS; Cooke TG; Symonds RP; MacLean AB; Stanton PD
    Br J Cancer; 1993 Jul; 68(1):166-71. PubMed ID: 8318408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of proliferating cell nuclear antigen (PCNA) staining and BrdUrd-labelling index under different proliferative conditions in vitro by flow cytometry.
    Lohr F; Wenz F; Haas S; Flentje M
    Cell Prolif; 1995 Feb; 28(2):93-104. PubMed ID: 7893842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell proliferation and differentiation in squamous cancer.
    Dische S; Saunders MI; Bennett MH; Wilson GD; McNally NJ
    Radiother Oncol; 1989 May; 15(1):19-23. PubMed ID: 2748939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular kinetics in rectal cancer.
    Terry NH; Meistrich ML; Roubein LD; Lynch PM; Dubrow RA; Rich TA
    Br J Cancer; 1995 Aug; 72(2):435-41. PubMed ID: 7640229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of radiation therapy on the potential doubling time of tumours in colorectal cancers.
    Michel P; Paresy M; Lepessot F; Mauillon J; Seng S; Scotte M; Peillon C; Ducrotté P; Hemet J; Paillot B
    Eur J Gastroenterol Hepatol; 1999 Mar; 11(3):309-14. PubMed ID: 10333205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetic heterogeneity of an experimental tumour revealed by BrdUrd incorporation and mathematical modelling.
    Bertuzzi A; Faretta M; Gandolfi A; Sinisgalli C; Starace G; Valoti G; Ubezio P
    Bull Math Biol; 2002 Mar; 64(2):355-84. PubMed ID: 11926121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proliferative characteristics of head and neck tumors. In vivo evaluation by bromodeoxyuridine incorporation and flow cytometry.
    Benazzo M; Mevio E; Occhini A; Franchini G; Danova M
    ORL J Otorhinolaryngol Relat Spec; 1995; 57(1):39-43. PubMed ID: 7700609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal DNA synthesis in polyamine deficient cells revealed by bromodeoxyuridine-flow cytometry technique.
    Fredlund JO; Johansson M; Baldetorp B; Oredsson SM
    Cell Prolif; 1994 May; 27(5):243-56. PubMed ID: 10465009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measuring potential doubling times of murine tumors using flow cytometry.
    Carlton JC; Terry NH; White RA
    Cytometry; 1991; 12(7):645-50. PubMed ID: 1782833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth of human prostate carcinomas with and without hormone alpha- dehydrotestosterone in nude mice.
    Baisch H; Otto U; Fack H
    Eur Urol; 1998 Dec; 34(6):505-11. PubMed ID: 9831793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample.
    Eidukevicius R; Characiejus D; Janavicius R; Kazlauskaite N; Pasukoniene V; Mauricas M; Den Otter W
    BMC Cancer; 2005 Sep; 5():122. PubMed ID: 16176590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell kinetics of human ovarian cancer with in vivo administration of bromodeoxyuridine.
    Erba E; Giordano M; Danova M; Mazzini G; Ubezio P; Torri V; Mangioni C; Landoni F; Bolis P; Tenti P
    Ann Oncol; 1994 Sep; 5(7):627-34. PubMed ID: 7993839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.